Scienture Holdings, Inc. — Director's Dealing 2021

Jun 2, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TRxADE HEALTH, INC (MEDS)
CIK: 0001382574
Period of Report: 2021-05-27

Reporting Person: Tenaerts Pamela (Former Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-05-27	Common stock	D	8041	—	Disposed	10867	Direct

Footnotes

F1: The shares were forfeited back to the Issuer as the reporting person discontinued service to the Issuer as of May 27, 2021, due to the vesting conditions pertaining to the award not having been achieved. Exempt under Rule 16b-3(e).